TAPI

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTAPI
Drug Alias NameTIMP and AAT fusion protein (Arriva)nTAPI
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionLeukocyte elastase inhibitorsMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinaseLeukocyte elastase
Therapy Area/IndicationsRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArriva Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArriva Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A